Showing results (331-340 of 378) with videos related to

Sort By:
Pageof 38
Journal of Cardiac Failure|August 9, 2023
Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced TrialMuhammad Shahzeb Khan, Stefan D Anker, Gerasimos Filippatos, et al.
Journal of Cardiac Failure|November 4, 2022
Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron DeficiencyMuhammad Shahzeb Khan, Stefan D Anker, Tim Friede, et al.
The American Journal of Cardiology|July 7, 2023
Association of Chronic Renal Insufficiency with Inhospital Outcomes in Primary Heart Failure Hospitalizations (Insights from the National Inpatient Sample 2004 to 2018)Abdul Mannan Khan Minhas, Huzefa M Bhopalwala, Nakeya Dewaswala, et al.
Journal of Cardiac Failure|February 19, 2020
Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 TrialJaved Butler, Muhammad Shahzeb Khan, Stefan D Anker, et al.
JAMA Network Open|April 18, 2020
Prevalence of Multiplicity and Appropriate Adjustments Among Cardiovascular Randomized Clinical Trials Published in Major Medical JournalsMuhammad Shahzeb Khan, Maaz Shah Khan, Zunaira Navid Ansari, et al.
Journal of the American College of Cardiology|July 15, 2026
The Role of Coronary Artery Calcium in Statin Eligibility Based on the American Heart Association's PREVENT Calculator: Insights From MESARishi Rikhi, Haiying Chen, Saeid Mirzai, et al.
European Journal of Heart Failure|March 25, 2022
Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiencyStefan D Anker, Piotr Ponikowski, Muhammad Shahzeb Khan, et al.
JACC. Heart Failure|May 3, 2023
Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIAJaved Butler, Yinggan Zheng, Muhammad Shahzeb Khan, et al.
Pageof 38